Cite
HARVARD Citation
Li, Q. et al. (2023). Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy. Cancer medicine. pp. 4110-4124. [Online].